This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
September 2023 saw a wave of new pharmaceuticalmanufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey.
The International Finance Corporation, the division of the World Bank Group that invests in the private sectors of emerging markets, has provided financing for several emerging market pharmaceuticalmanufacturers with the goal of boosting developing countries’ access to affordably priced drugs. About the author. Dr Subir K.
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceuticalmanufacturing site quality rating system, the Quality management maturity (QMM) programme.
Commercial dose companies form a critical component of the pharmaceuticalmanufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables.
So what do exactly HEOR experts do for the pharmaceuticalcompanies and what HEOR-collected data is used for? Defining Drugs Dosage Even when all stages of the clinical trial are over, there are still many things pharmacists and doctors may learn after patients will get access to the new treatment. What is HEOR Data?
Hidden expenses can pile up, spiraling out of control due to many reasons related to supplier performance: the lack of appropriate documentation, storage, wrong dosage forms, and the list goes on. Technologies allow pharmaceuticalcompanies to collect and analyze a massive amount of data to ensure proper drug safety.
PCM not ideal for every drug Continuous manufacturing “may not be fit for every pharmaceuticalmanufacturing process, but it can bring some advantages in some cases” compared with traditional batch manufacturing, summarized FDA’s Adam Fisher, Ph.D.,
The practice of calling a piece of equipment clean just because it looks clean is not acceptable in the pharmaceuticalmanufacturing process. Kazi holds several pharmaceutical industry certifications including post-graduate degrees in Engineering Management and Business Administration. Why is cleaning validation required?
Pharmaceuticalmanufacturers must have written procedures on the steps to take when any result does not meet specifications. To replace the single invalidated result, you should test one additional dosage unit for the content uniformity test or perform a dissolution test using one dosage unit.
Quality is everyone’s responsibility, and it should pervade every aspect of pharmaceuticalmanufacture and packaging. Quality should not be tested into products; instead, it must be built in at each step of manufacture. Pharmaceuticalmanufacturers must integrate the key functions of the quality control process.
Pharmaceuticalcompanies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. Combining methods of coding for both end solutions has, in the past, been the biggest challenge. .
Name, source, manufacturing sites, and date of manufacture of drug substance) – Dosage form and strength, including formulation – Composition, type, source, size of container, and closure – Specifications and test methodology (I.e., – Routine recording of environmental parameters (e.g.,
The FDA sets stringent requirements for operational qualification for critical equipment and systems to ensure the safety and efficacy of pharmaceutical products. These requirements mandate that pharmaceuticalcompanies thoroughly document OQ protocols, testing methods, acceptance criteria, and results.
Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceuticalmanufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).
Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content